Home > Formulary : Paediatric > Recent Decisions > 2022 >
Decisions 15th March 2022
Decisions 15th March 2022
At the meeting on the 15th March, the following decisions were agreed
New Drug Requests
Approved
Sucralfate liquid (oral) (TLS Red)
-
For treatment of oral mucositis for oncology and haematology patients
Acarizax (oral) (TLS Red)
-
For adolescents and adults with severe rhinitis or house dust mite allergic asthma
Shared Care Protocols/ TLS Status Changes
-
nil
Updated SCPs
-
nil
Further Work
Melatonin
Work across the BNSSG system is taking place over the next year to review existing and proposed indications for inclusion to the formulary. Further information will be available following discussion of these applications at Joint Formulary Group meetings (expected to discuss September 2022 and December 2022).